Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)

ClinicalTrials.gov ID: NCT01662063

Public ClinicalTrials.gov record NCT01662063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 8:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Open-Label, Long-Term Extension Study of WA22762 and NA25220 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label extension study will evaluate the long-term safety and efficacy of SC TCZ in participants with moderate to severe RA who have completed the 97-week WA22762 (NCT01194414) or 96-week NA25220 (NCT01232569) core studies on SC or intravenous (IV) TCZ. Participants will receive TCZ 162 milligrams (mg) SC every week (QW) or every 2 weeks (Q2W) for up to 96 weeks.

Study identification

NCT ID
NCT01662063
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genentech, Inc.
Industry
Enrollment
218 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2012
Primary completion
Mar 31, 2014
Completion
May 31, 2014
Last update posted
Oct 11, 2016

2012 – 2014

United States locations

U.S. sites
78
U.S. states
30
U.S. cities
71
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama 35406 —
Not listed Peoria Arizona 85381 —
Not listed Scottsdale Arizona 85258 —
Not listed Tucson Arizona 85704 —
Not listed Tucson Arizona 85715 —
Not listed Tucson Arizona 85723 —
Not listed Tucson Arizona 85724 —
Not listed Fullerton California 92835 —
Not listed Long Beach California 90806 —
Not listed Los Angeles California 90048 —
Not listed San Diego California 92108 —
Not listed San Leandro California 94578 —
Not listed Upland California 91786 —
Not listed Van Nuys California 91405 —
Not listed West Hills California 91307 —
Not listed Whittier California 90606 —
Not listed Denver Colorado 80230-7127 —
Not listed Bridgeport Connecticut 06606 —
Not listed Trumbull Connecticut 06611 —
Not listed Jupiter Florida 33458 —
Not listed Orlando Florida 32806 —
Not listed Palm Harbor Florida 34684 —
Not listed South Miami Florida 33143 —
Not listed Tampa Florida 33614 —
Not listed Venice Florida 34233 —
Not listed Gainesville Georgia 30501 —
Not listed Coeur d'Alene Idaho 83814 —
Not listed Idaho Falls Idaho 83404 —
Not listed Meridian Idaho 83642 —
Not listed Morton Grove Illinois 60053 —
Not listed Springfield Illinois 62703 —
Not listed Vernon Hills Illinois 60061 —
Not listed Wichita Kansas 67208 —
Not listed Monroe Louisiana 71203 —
Not listed Hagerstown Maryland 21740 —
Not listed Wheaton Maryland 20902 —
Not listed Worcester Massachusetts 01605 —
Not listed Saint Claire Shores Michigan 48081 —
Not listed Eagan Minnesota 55121 —
Not listed Flowood Mississippi 39232 —
Not listed Jackson Mississippi 39202 —
Not listed Florissant Missouri 63031 —
Not listed St Louis Missouri 63117 —
Not listed St Louis Missouri 63141 —
Not listed Lincoln Nebraska 68516 —
Not listed Lebanon New Hampshire 03756 —
Not listed Clifton New Jersey 07012 —
Not listed Freehold New Jersey 07728 —
Not listed Manalapan New Jersey 07726 —
Not listed Voorhees Township New Jersey 08043 —
Not listed Albuquerque New Mexico 87102 —
Not listed Albany New York 12206 —
Not listed Brooklyn New York 11201 —
Not listed Orchard Park New York 14127 —
Not listed Asheville North Carolina 28803 —
Not listed Charlotte North Carolina 28210 —
Not listed Raleigh North Carolina 27615 —
Not listed Wilmington North Carolina 28401 —
Not listed Cincinnati Ohio 45219 —
Not listed Perrysburg Ohio 43551 —
Not listed Toledo Ohio 43606 —
Not listed Oklahoma City Oklahoma 73103 —
Not listed Oklahoma City Oklahoma 73104 —
Not listed Tulsa Oklahoma 74135 —
Not listed Bethlehem Pennsylvania 18015 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Wyomissing Pennsylvania 19610 —
Not listed Charleston South Carolina 29407 —
Not listed Knoxville Tennessee 37909 —
Not listed Memphis Tennessee 38104 —
Not listed Memphis Tennessee 38119 —
Not listed Houston Texas 77004 —
Not listed Houston Texas 77074 —
Not listed Nassau Bay Texas 77058 —
Not listed Olympia Washington 98502 —
Not listed Seattle Washington 98104 —
Not listed Spokane Washington 99204 —
Not listed Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01662063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2016 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01662063 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →